Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Freeman

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
Clinical Epigenetics|February 7, 2017
UroMark-a urinary biomarker assay for the detection of bladder cancerAndrew Feber, Pawan Dhami, Liqin Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate CancerHarveer Dev, Mark Linch, Krishna Narahari, et al.
The Prostate|August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostatesJonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
European Urology Oncology|November 5, 2024
Management of Small Testicular Masses: A Delphi Consensus StudyKarl H Pang, Giuseppe Fallara, João Lobo, et al.
Trials|July 22, 2022
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancerEoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, et al.
Health Technology Assessment (Winchester, England)|July 25, 2018
Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS studyLouise Clare Brown, Hashim U Ahmed, Rita Faria, et al.
European Urology|May 7, 2020
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS CohortJoseph M Norris, Lina M Carmona Echeverria, Simon R J Bott, et al.
The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES StudyGianmarco Leone, Yien Ning Sophia Wong, Robert J Jones, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
Clinical Epigenetics|February 7, 2017
UroMark-a urinary biomarker assay for the detection of bladder cancerAndrew Feber, Pawan Dhami, Liqin Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate CancerHarveer Dev, Mark Linch, Krishna Narahari, et al.
The Prostate|August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostatesJonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
European Urology Oncology|November 5, 2024
Management of Small Testicular Masses: A Delphi Consensus StudyKarl H Pang, Giuseppe Fallara, João Lobo, et al.
Trials|July 22, 2022
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancerEoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, et al.
Health Technology Assessment (Winchester, England)|July 25, 2018
Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS studyLouise Clare Brown, Hashim U Ahmed, Rita Faria, et al.
European Urology|May 7, 2020
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS CohortJoseph M Norris, Lina M Carmona Echeverria, Simon R J Bott, et al.
The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.
European Urology|October 1, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST TrialAlexander Light, Abi Kanthabalan, Marjorie Otieno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES StudyGianmarco Leone, Yien Ning Sophia Wong, Robert J Jones, et al.
Pageof 25